Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.89M | 3.70M | 1.47M | 1.65M | 3.23M |
Total Receivables | 587.00K | 558.40K | 1.39M | 1.56M | 366.50K |
Inventory | 90.20K | 85.80K | 85.10K | 95.30K | 64.10K |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 70.30K | 66.90K | 32.10K | 35.90K | 93.30K |
Total Current Assets | 4.64M | 4.41M | 2.98M | 3.34M | 3.75M |
|
|||||
Total Current Assets | 4.64M | 4.41M | 2.98M | 3.34M | 3.75M |
Net Property, Plant & Equipment | 67.10K | 63.80K | 105.70K | 118.40K | 160.80K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 10.30K | 9.80K | 9.70K | 10.90K | -- |
Total Assets | 4.72M | 4.49M | 3.09M | 3.46M | 3.91M |
|
|||||
Total Accounts Payable | 433.30K | 412.20K | 37.50K | 42.00K | 650.60K |
Total Accrued Expenses | -- | -- | 348.70K | 390.70K | -- |
Short-term Debt | -- | -- | 605.50K | 678.40K | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 37.50K | 35.60K | 51.80K | 58.10K | 53.60K |
Total Finance Division Other Current Liabilities | 532.80K | 506.80K | 14.90K | 16.70K | 356.10K |
Total Other Current Liabilities | 532.80K | 506.80K | 14.90K | 16.70K | 356.10K |
Total Current Liabilities | 1.00M | 954.70K | 1.06M | 1.19M | 1.06M |
|
|||||
Total Current Liabilities | 1.00M | 954.70K | 1.06M | 1.19M | 1.06M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | 605.50K | 678.40K | -- |
Capital Leases | -- | -- | 9.00K | 10.00K | 38.10K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 3.17M | 3.02M | 1.40K | 1.50K | 1.10K |
Total Liabilities | 4.17M | 3.97M | 1.07M | 1.20M | 1.10M |
|
|||||
Common Stock & APIC | 160.38M | 152.57M | 151.37M | 169.59M | 163.20M |
Retained Earnings | -178.37M | -169.68M | -166.71M | -186.78M | -179.28M |
Treasury Stock & Other | 18.53M | 17.63M | 17.36M | 19.45M | 18.89M |
Total Common Equity | 541.00K | 514.60K | 2.02M | 2.27M | 2.81M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 541.00K | 514.60K | 2.02M | 2.27M | 2.81M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 541.00K | 514.60K | 2.02M | 2.27M | 2.81M |
|